|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for AKR1B1 |
Basic gene info. | Gene symbol | AKR1B1 |
Gene name | aldo-keto reductase family 1, member B1 (aldose reductase) | |
Synonyms | ADR|ALDR1|ALR2|AR | |
Cytomap | UCSC genome browser: 7q35 | |
Genomic location | chr7 :134127106-134143888 | |
Type of gene | protein-coding | |
RefGenes | NM_001628.2, | |
Ensembl id | ENSG00000085662 | |
Description | Lii5-2 CTCL tumor antigenaldehyde reductase 1aldo-keto reductase family 1 member B1aldose reductaselow Km aldose reductase | |
Modification date | 20141207 | |
dbXrefs | MIM : 103880 | |
HGNC : HGNC | ||
Ensembl : ENSG00000085662 | ||
HPRD : 00071 | ||
Vega : OTTHUMG00000155322 | ||
Protein | UniProt: P15121 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_AKR1B1 | |
BioGPS: 231 | ||
Gene Expression Atlas: ENSG00000085662 | ||
The Human Protein Atlas: ENSG00000085662 | ||
Pathway | NCI Pathway Interaction Database: AKR1B1 | |
KEGG: AKR1B1 | ||
REACTOME: AKR1B1 | ||
ConsensusPathDB | ||
Pathway Commons: AKR1B1 | ||
Metabolism | MetaCyc: AKR1B1 | |
HUMANCyc: AKR1B1 | ||
Regulation | Ensembl's Regulation: ENSG00000085662 | |
miRBase: chr7 :134,127,106-134,143,888 | ||
TargetScan: NM_001628 | ||
cisRED: ENSG00000085662 | ||
Context | iHOP: AKR1B1 | |
cancer metabolism search in PubMed: AKR1B1 | ||
UCL Cancer Institute: AKR1B1 | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of AKR1B1 in cancer cell metabolism | 1. Uzozie A, Nanni P, Staiano T, Grossmann J, Barkow-Oesterreicher S, et al. (2014) Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study. Mol Cell Proteomics 13: 1198-1218. doi: 10.1074/mcp.M113.035105. pmid: 4014279 go to article 2. Balendiran GK, Martin HJ, El-Hawari Y, Maser E (2009) Cancer biomarker AKR1B10 and carbonyl metabolism. Chem Biol Interact 178: 134-137. doi: 10.1016/j.cbi.2008.10.044. go to article |
Top |
Phenotypic Information for AKR1B1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: AKR1B1 |
Familial Cancer Database: AKR1B1 |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM KEGG_GALACTOSE_METABOLISM KEGG_GLYCEROLIPID_METABOLISM KEGG_PYRUVATE_METABOLISM REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Others | |
OMIM | 103880; gene. |
Orphanet | |
Disease | KEGG Disease: AKR1B1 |
MedGen: AKR1B1 (Human Medical Genetics with Condition) | |
ClinVar: AKR1B1 | |
Phenotype | MGI: AKR1B1 (International Mouse Phenotyping Consortium) |
PhenomicDB: AKR1B1 |
Mutations for AKR1B1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows AKR1B1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BG009392 | TBCD | 61 | 156 | 17 | 80790096 | 80790191 | AKR1B1 | 148 | 340 | 7 | 134134452 | 134135632 | |
AV708454 | KDM4A | 1 | 92 | 1 | 44166118 | 44166263 | AKR1B1 | 87 | 391 | 7 | 134134330 | 134135623 | |
AV701562 | PHF15 | 1 | 86 | 5 | 133860064 | 133871576 | AKR1B1 | 81 | 649 | 7 | 134127108 | 134132119 | |
AI654627 | AKR1B1 | 7 | 238 | 7 | 134127108 | 134127339 | PPP1R21 | 228 | 501 | 2 | 48718191 | 48725693 | |
AV705293 | AKR1B1 | 48 | 688 | 7 | 134130004 | 134135656 | ITK | 672 | 695 | 5 | 156679776 | 156679822 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
There's no copy number variation information in COSMIC data for this gene. |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=21) | (# total SNVs=10) |
(# total SNVs=1) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr7:134134532-134134532 | p.F123F | 5 |
chr7:134133183-134133183 | p.I205I | 3 |
chr7:134132069-134132069 | p.R269H | 2 |
chr7:134132761-134132761 | p.A238T | 2 |
chr7:134134517-134134517 | p.S128S | 2 |
chr7:134132815-134132815 | p.? | 1 |
chr7:134143774-134143774 | p.P14R | 1 |
chr7:134132056-134132056 | p.N273K | 1 |
chr7:134136364-134136364 | p.R70C | 1 |
chr7:134133142-134133142 | p.P219L | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 |   |   | 9 |   |   | 2 |   | 2 | 1 |   | 6 | 1 | 5 |   |   | 9 | 7 |   |   |
# mutation | 1 |   |   | 7 |   |   | 2 |   | 2 | 1 |   | 6 | 1 | 5 |   |   | 4 | 9 |   |   |
nonsynonymous SNV | 1 |   |   | 5 |   |   | 2 |   | 1 |   |   | 5 | 1 | 4 |   |   | 1 | 6 |   |   |
synonymous SNV |   |   |   | 2 |   |   |   |   | 1 | 1 |   | 1 |   | 1 |   |   | 3 | 3 |   |   |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr7:134134532 | p.F123F | 6 |
chr7:134132069 | p.R269H | 3 |
chr7:134132761 | p.A238T | 2 |
chr7:134133231 | p.N257D | 1 |
chr7:134135631 | p.P113L | 1 |
chr7:134132059 | p.F252L | 1 |
chr7:134143812 | p.L109L | 1 |
chr7:134133770 | p.R251Q | 1 |
chr7:134135632 | p.Y104C | 1 |
chr7:134133802 | p.K86K | 1 |
Other DBs for Point Mutations |
Copy Number for AKR1B1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for AKR1B1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AKR1B10,AKR1C1,AKR1C3,ALDH3A1,BCL2L10,C10orf99,FOXE1, GAGE12J,GAGE2B,GAGE8,GPX2,IQCF2,KRT13,KRT74, LOC285629,NKX2-4,RBMXL2,UGT1A5,VCX,VCX3A,VCY | ADH7,AKR1B10,ALDH3A1,C10orf99,CAPNS2,CYP4F3,GJB6, KRT13,KRT4,KRT6A,KRT78,KRTDAP,SOX2,SPRR1A, SPRR1B,SPRR2A,SPRR2D,SPRR3,TMPRSS11D,UGT1A7,UPK1B | ||||
AKR1B10,AKR1B15,BTNL3,C11orf86,MIEN1,AXDND1,DHRS9, ERBB2,KRT20,MALL,MMP28,MSL1,PPP1R1B,RAPGEFL1, TCAP,TMEM54,TMEM82,TSPAN1,UGT1A1,UGT1A8,WIPF2 | ABCD3,AKR1B10,AP1AR,CROT,CRYL1,CTAGE5,ETFDH, FAM73B,FLVCR2,HADHB,KALRN,NCOA4,OCIAD2,PDXP, PRR13,RBKS,RRAS2,STK17B,TMEM139,SLC35G1,UGT1A9 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for AKR1B1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | BindingDB | P15121; -. |
Chemistry | ChEMBL | CHEMBL1900; -. |
Chemistry | GuidetoPHARMACOLOGY | 2768; -. |
Organism-specific databases | PharmGKB | PA24675; -. |
Organism-specific databases | CTD | 231; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00157 | aldo-keto reductase family 1, member B1 (aldose reductase) | approved; nutraceutical | NADH | ||
DB00605 | aldo-keto reductase family 1, member B1 (aldose reductase) | approved | Sulindac | ||
DB01689 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Inhibitor Idd 384 | ||
DB02007 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Alpha-D-Glucose-6-Phosphate | ||
DB02020 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Alrestatin | ||
DB02021 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Fidarestat | ||
DB02101 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Fidarestat(Stereoisomer) | ||
DB02132 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | [3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid | ||
DB02383 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Tolrestat | ||
DB02518 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | N-Acetylalanine | ||
DB02712 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Sorbinil | ||
DB02834 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | IDD552 | ||
DB02994 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Hydroxydimethylarsine Oxide | ||
DB03461 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 2'-Monophosphoadenosine 5'-Diphosphoribose | ||
DB04272 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | Citric Acid | ||
DB07028 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | (2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID | ||
DB07030 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | ||
DB07063 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | {3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID | ||
DB07093 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | {3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID | ||
DB07139 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid | ||
DB07187 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE | ||
DB07450 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE | ||
DB07498 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID | ||
DB07999 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID | ||
DB08000 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | ||
DB08084 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | IDD594 | ||
DB08098 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | {[5-(5-NITRO-2-FURYL)-1,3,4-OXADIAZOL-2-YL]THIO}ACETIC ACID | ||
DB08449 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid | ||
DB08772 | aldo-keto reductase family 1, member B1 (aldose reductase) | experimental | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID |
Top |
Cross referenced IDs for AKR1B1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |